US 9814695
Ophthalmic solutions for glaucoma and conjunctivitis treatment
granted A61KA61K31/05A61K31/352
Quick answer
US patent 9814695 (Ophthalmic solutions for glaucoma and conjunctivitis treatment) held by AXIM BIOTECHNOLOGIES. INC. expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXIM BIOTECHNOLOGIES. INC.
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K31/658, A61K9/0048